Job Summary
The National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) is seeking exceptional candidates for the position of Director, Center for Clinical Trials Network (CCTN). NIDA's mission is to lead the nation in bringing the power of science to bear on drug misuse and addiction. This charge has two critical components: strategic support and conduct of research across a broad range of disciplines, and ensuring the rapid and effective dissemination of research results to improve practice and inform policy related to drug misuse and addiction. CCTN’s mission is to bridge the gap between addiction science and addiction clinical care, establish bi-directional conversation between scientists and providers, enhance the adoptability of evidence-based treatment, and improve the nation’s substance use disorder (SUD) treatment using science as the vehicle.
The Director for the Center for Clinical Trials Network (CCTN) provides scientific executive leadership and direction for a complex extramural clinical research program of national and international scope within NIDA. The CCTN Director oversees all aspects of the Center's clinical research and clinical trials and is one of the top five senior leadership positions that directly reports to and advises the NIDA Director.
The CCTN Director administers the scientific, administrative, budgetary, and operational management of the National Drug Abuse Treatment Clinical Trials Network (CTN). The CTN is a program of multi-site clinical trials evaluating behavioral, pharmacological, and integrated treatment interventions to determine their effectiveness across a broad range of community-based treatment settings and diversified patient populations. CTN has a multifaceted programmatic framework that currently comprises 16 Nodes spanning the country, a Clinical Coordinating Center, and a Data and Statistics Center. CTN Node staff include principal investigators and co-investigators from 82 institutions, and more than 200 community-based providers representing hospitals, clinics, treatment centers, and private practices. CTN has an annual budget of $72M which includes a contracts portfolio totaling $23M per year for additional professional staff to provide the requisite infrastructure and resources for conducting clinical research.
The Director of the CCTN has line authority of up to 15 scientific professionals with the multi-disciplinary training and experience required to oversee and manage a broad portfolio of clinical trials and other clinical research. As the CTN serves as a national resource, the CCTN Director interacts with NIDA division directors and represents NIDA in NIH-wide activities relevant to clinical research; establishes collaborative relationships with other sister HHS agencies, e.g., Food and Drug Administration (FDA), Health Resources and Services Administration (HRSA), Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Disease Control and Prevention (CDC), etc. on regulatory and/or science implementation issues; and interacts with other experts in the field, e.g., the Directors of Drug and Alcohol Single State Agencies and their constituent association, presidents and executive directors of professional organizations, and senior scientists and managers of the pharmaceutical and healthcare device industries.
Required Qualifications
The National Institute on Drug Abuse seeks candidates who have a commitment to scientific excellence and the energy, enthusiasm, and innovative thinking necessary to lead a dynamic and diverse organization. Applicants must possess an M.D. and/or Ph.D. degree in a discipline relevant to neurobiology, substance use disorders, or clinical trials, and have extensive knowledge and experience in the design, implementation, and monitoring of large multi-site clinical trials. Highly developed management skills, exceptional communication skills, and strong multi-dimensional leadership skills in administering large complex scientific research programs/organizations are greatly desirable. The successful candidate must also have knowledge and experience with regulatory requirements pertaining to interactions with FDA, Drug Enforcement Administration (DEA), and other federal agencies, serving on national boards or advisory groups, preparing materials for briefings, hearings, or reports to senior management or trans-agency groups, and presenting at national or international meetings relevant to clinical trials, SUD treatment, and policies surrounding these areas. This position will be filled under a Title 42 (f) excepted service appointment.
Benefits
Salary will be commensurate with the experience of the candidate. A full package of Federal Civil Service benefits is available, including retirement, health and life insurance, annual and sick leave, and a Thrift Savings Plan (401K equivalent). A recruitment and/or relocation incentive may be available and relocation expenses will be paid. At the supervisor's discretion, this position may offer workplace flexibilities, including situational telework.
Equal Employment Opportunity
Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. The NIH encourages the application and nomination of qualified women, minorities, and individuals with disabilities.
Job Details
Open Date: Fri, 08/09/24
Close Date: Open until filled
IC: NIDA (National Institute on Drug Abuse)
Location: Rockville, MD
Pay: Commensurate with qualifications and experience
How to Apply:
Applicants must submit a current curriculum vitae, cover letter of interest including a brief description of experience, and full contact details for three references to: Maryann Postorino, Office of Human Resources, National Institutes of Health. We recommend including a narrative that addresses recruiting, mentoring, training and/or outreach activities, especially those involving women and persons from racial/ethnic or other groups that are underrepresented. No photographs are allowed in the documents and must be removed prior to applying. Applications will be accepted beginning August 9, 2024. Position is open until filled. Applications will begin review by the search committee on October 8, 2024.
Applications will be accepted from U.S. citizens and non-citizens as allowed by appropriations and statute. Applications from women, persons from underrepresented groups, and persons with disabilities are strongly encouraged.
Please direct any inquiries about the position or about the application process to Amy Patterson, Ph.D.
#J-18808-Ljbffr
